CLINICAL_TRIALS
trial_result
· 2020-07-01
Clinical Trial Update: Oral Enzastaurin in Participants With Relapsed Mantle Cell Lymphoma [Phase 2]
Summary
Phase 2 trial update for oral enzastaurin in relapsed mantle cell lymphoma has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Mantle-Cell Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2020-07-01